An Onsite Class
Did you know that investing in private startup companies has historically returned at rates higher than the market indices like the S&P 500? The Sharks on Shark Tank certainly do and this is one of the compelling reasons why angel investors invest in startups as well as the enjoyment of supporting young companies from the ground up, among a host of other reasons.
If you are seeking a primer into the world of startup investing, then we invite you to register for our class!
By the end, you will gain an understanding of:
We’ll wrap with a Meet-Greet session with some investor members from angel groups in the DC-Baltimore region, including Baltimore Angels, Keiretsu Forum, Private Access Network, MEDA Angels and others TBA!
The class will be taught by experienced investors who are founders of their own angel investor groups.
POSTPONED. We invite you to consider our online e-class option in the meantime.
Next Date: Fri, May, 31 2019
Location: 2020 K St, NW,
11th Floor, Washington, DC 20006
Offices of Jones Lang Lasalle
(near Farragut North Metro)
Class limit: 25
Breakfast, Lunch, Refreshments to be Served
9:15 – 9:30
Check-in & Welcome
9:30 – 11:00
History of Angel Investing
Investment Types Along the Capital Stack
Benefits : Risks of Angel Investing
Due Diligence Process
Key Points to Research into a Startup
11:00 – 11:15
Meet the Sponsor
11:15 – 12:30
More Due Diligence
Financial Points to Evaluate
12:30 – 1:30
1:00 – 2:00
Term Sheet Essentials
2:00 – 3:00
Elizabeth is a scientist-turned-angel investor. She is the Founder of Venture Corner and Co-Founder & Managing Director of MEDA Angels, a healthcare angel investor group. Her investment & teaching activities are based on 25+ years of cross-functional experience in the life sciences area including bench cancer research at the NIH, Georgetown & Harvard Medical Schools where her work on cancer epigenetics resulted in publications at the highest impact levels (Nature, Nature Cell Biology, PNAS); regulatory affairs at biotech companies including Macrogenics and RegenxBio involving Investigational New Drug Applications, Clinical Trial Protocols/Amendments, Data Safety Reports & Fast Track Applications for cancer & gene therapy drugs; grants administration for the DoD & NIH where she developed genomics, proteomics and other high throughput-based grant requests and led nearly 20 grant review panels ranging from proof of concept to clinical trial grants. Over the past decade, she has been focused on private placement funding as an angel investor in early stage healthcare, e-commerce and SaaS startups, and as an active mentor and strategic advisor to dozens of startups, angel investors & family offices. She is also an Instructor at Johns Hopkins Carey Business School and teaches Startup Funding as part of the Technology Entrepreneurship class series. She received her BA from Johns Hopkins, MS from Georgetown University, PhD from Thomas Jefferson University & completed postdoctoral fellowships at NIH & Harvard Medical School.
Randy is the Founder and Managing Director for Private Access Network, an angel investor group. He is a seasoned technology and venture capital executive with over 20 years of experience in senior management, business development and financial roles. Randy has extensive experience building and maintaining over $100 million of venture capital and private equity fund-of-funds for institutional, municipal and individual investors at entities including GKM Newport. Randy is also the Managing Director for Liquid Capital Group. Since 2000, Liquid Capital Group has been managing portfolios of top venture funds and superior emerging information technology companies for high net worth individuals and families. Between 2006 and 2009, Randy was also a Managing Director at GKM Newport, a venture capital and private equity fund-of-funds manager with over $1 billion in assets under management. Randy has also held a variety of finance, marketing and sales positions with MCI Communications, Inc. and was a consultant to the energy, pharmaceutical and automobile industries while at Putnam, Hayes & Bartlett. Randy holds a B.A. in Economics and Environmental Studies from the University of Pennsylvania. He has also studied at Harvard University and the University of Connecticut.
Brent Salmons represents public and private companies and investors in a broad range of corporate and financial matters, including mergers and acquisitions, business formation and governance, financing, and debt restructurings. Brent has extensive experience in the energy and project finance, telecommunications, media and technology, and real estate industries. He has represented clients as a real estate lawyer in transactions ranging from $50,000 to over $1 billion in mergers and acquisition and capital funding. Representative transactions include: (1) multiple venture capital funds in their investments in technology firms, (2) Lockheed Martin in its sale of COMSAT International; (3) ad hoc committee of bonders on the financial restructuring and settlement of certain bonds of Norse Energy, an oil and gas exploration and production company; (4) co-developers in the development and approximately $1.5 billion financing of a new 540MW combined cycle natural gas fired electric generation facility to be built by Astoria energy II in NYC – named 2009 Americas Power Deal of the Year by Project Finance International; (5) several Washington, D.C. real estate development firms in the formation of several real estate limited partnerships, each with investments of more than $100M; and (6) a major Washington, D.C. real estate development firm in its formation of a real estate investment trust with investment of over $200M. Brent received his BA in Accounting from Missouri State University and his JD from Georgetown University Law Center.